Featured Research

from universities, journals, and other organizations

New Polymer Shows Promise Against Ovarian Cancer

Date:
March 30, 2000
Source:
American Chemical Society
Summary:
The first synthetic rubber that kills bacteria and other pathogenic organisms on contact was described here today at the 219th national meeting of the American Chemical Society, the world’s largest scientific society. The material — whose killing power is renewable — proved effective in laboratory tests against Staphylococcus aureus and other major sources of hospital infections.

Effectiveness in Lab Tests Unexpected

SAN FRANCISCO, March 28 — A new polymer derived from an antibacterial drug has unexpectedly and dramatically inhibited the growth of ovarian cancer cell lines previously thought to be resistant to drugs, according to researchers at Florida Atlantic University in Boca Raton.

Both cell lines were obtained from ovarian cancer patients previously treated by conventional chemotherapy, including the drugs cytoxan, adriamycin and cisplatin. The new polymer-drug combination inhibited the growth of one cancer cell line by 97 percent and another by 80 percent.

The findings were presented here today at the 219th national meeting of the American Chemical Society, the world’s largest scientific society. The weeklong meeting is expected to attract about 20,000 scientists from around the world.

The investigation, carried out by Charles Carraher, Ph.D., and Deborah Siegmann-Louda, Ph.D., involves modifying existing drugs by incorporating them in metal-containing polymers. In this case, the antibacterial drug cephalexin and a polymer containing tin were used. By itself, cephalexin — marketed under the names Keflex and Keftabis — not active against the cell lines tested, Carraher notes.

The new polymer’s effectiveness makes it a potential “candidate as a last-defense cancer drug,” according to the researchers.

Why the polymer is effective remains a mystery. But there appears to be a synergistic effect from the metal, according to Carraher: “When you make polymers without the metals, as far as we can tell, you don’t get much activity.”

The next step is to vary the metal and see if that has any effect on the cancer, he says. In addition to tin, the researchers have made polymers combining cephalexin with arsenic, alimony and bismuth; they are now being tested.

Carraher calls the findings “exciting,” but is quick to add a note of caution: “Nothing is a miracle cure.” More testing is needed, including animal studies. Still, Carraher believes the cell line findings are “promising” — enough so, he says, that he is reallocating resources from other research projects in his lab.

Dr. Carraher is Professor, Department of Chemistry and Biochemistry, Florida Atlantic University. He also is Associate Director, Florida Center forEnvironmental Studies.

Dr. Siegmann-Louda is Associate Professor, Department of Chemistry and Biochemistry, Florida Atlantic University.


Story Source:

The above story is based on materials provided by American Chemical Society. Note: Materials may be edited for content and length.


Cite This Page:

American Chemical Society. "New Polymer Shows Promise Against Ovarian Cancer." ScienceDaily. ScienceDaily, 30 March 2000. <www.sciencedaily.com/releases/2000/03/000329081511.htm>.
American Chemical Society. (2000, March 30). New Polymer Shows Promise Against Ovarian Cancer. ScienceDaily. Retrieved October 22, 2014 from www.sciencedaily.com/releases/2000/03/000329081511.htm
American Chemical Society. "New Polymer Shows Promise Against Ovarian Cancer." ScienceDaily. www.sciencedaily.com/releases/2000/03/000329081511.htm (accessed October 22, 2014).

Share This



More Health & Medicine News

Wednesday, October 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

CDC Revamps Ebola Guidelines After Criticism

CDC Revamps Ebola Guidelines After Criticism

Newsy (Oct. 21, 2014) The Centers for Disease Control and Prevention have issued new protocols for healthcare workers interacting with Ebola patients. Video provided by Newsy
Powered by NewsLook.com
WHO: Ebola Vaccine Trials to Start a in January

WHO: Ebola Vaccine Trials to Start a in January

AP (Oct. 21, 2014) Tens of thousands of doses of experimental Ebola vaccines could be available for "real-world" testing in West Africa as soon as January as long as they are deemed safe in soon to start trials, the World Health Organization said Tuesday. (Oct. 21) Video provided by AP
Powered by NewsLook.com
First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

Newsy (Oct. 21, 2014) A medical team has for the first time given a man the ability to walk again after transplanting cells from his brain onto his severed spinal cord. Video provided by Newsy
Powered by NewsLook.com
CDC Issues New Ebola Guidelines for Health Workers

CDC Issues New Ebola Guidelines for Health Workers

Reuters - US Online Video (Oct. 21, 2014) The U.S. Centers for Disease Control and Prevention has set up new guidelines for health workers taking care of patients infected with Ebola. Linda So reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins